JP2006526386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006526386A5 JP2006526386A5 JP2004561676A JP2004561676A JP2006526386A5 JP 2006526386 A5 JP2006526386 A5 JP 2006526386A5 JP 2004561676 A JP2004561676 A JP 2004561676A JP 2004561676 A JP2004561676 A JP 2004561676A JP 2006526386 A5 JP2006526386 A5 JP 2006526386A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- nucleic acid
- disease
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001184 polypeptide Polymers 0.000 claims 53
- 102000004196 processed proteins & peptides Human genes 0.000 claims 52
- 108090000765 processed proteins & peptides Proteins 0.000 claims 52
- 150000007523 nucleic acids Chemical class 0.000 claims 37
- 102000039446 nucleic acids Human genes 0.000 claims 35
- 108020004707 nucleic acids Proteins 0.000 claims 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 30
- 201000010099 disease Diseases 0.000 claims 28
- 238000000034 method Methods 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 16
- 239000003446 ligand Substances 0.000 claims 11
- 230000000694 effects Effects 0.000 claims 10
- 239000000523 sample Substances 0.000 claims 9
- 102000019034 Chemokines Human genes 0.000 claims 8
- 108010012236 Chemokines Proteins 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 7
- 239000013068 control sample Substances 0.000 claims 5
- 230000035772 mutation Effects 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 201000004681 Psoriasis Diseases 0.000 claims 4
- 206010040047 Sepsis Diseases 0.000 claims 4
- 230000000890 antigenic effect Effects 0.000 claims 4
- 208000006673 asthma Diseases 0.000 claims 4
- 238000003745 diagnosis Methods 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000002853 nucleic acid probe Substances 0.000 claims 3
- 239000013610 patient sample Substances 0.000 claims 3
- 239000008196 pharmacological composition Substances 0.000 claims 3
- 208000030507 AIDS Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010002383 Angina Pectoris Diseases 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 208000014912 Central Nervous System Infections Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010014568 Empyema Diseases 0.000 claims 2
- 208000037487 Endotoxemia Diseases 0.000 claims 2
- 206010017533 Fungal infection Diseases 0.000 claims 2
- 206010056663 Gastric infection Diseases 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 208000031888 Mycoses Diseases 0.000 claims 2
- 208000014767 Myeloproliferative disease Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000012902 Nervous system disease Diseases 0.000 claims 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 206010030113 Oedema Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 206010033647 Pancreatitis acute Diseases 0.000 claims 2
- 208000030852 Parasitic disease Diseases 0.000 claims 2
- 201000005702 Pertussis Diseases 0.000 claims 2
- 206010037660 Pyrexia Diseases 0.000 claims 2
- 206010063837 Reperfusion injury Diseases 0.000 claims 2
- 206010040070 Septic Shock Diseases 0.000 claims 2
- 208000007536 Thrombosis Diseases 0.000 claims 2
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 2
- 201000003229 acute pancreatitis Diseases 0.000 claims 2
- 208000037883 airway inflammation Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 230000001363 autoimmune Effects 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 238000009739 binding Methods 0.000 claims 2
- 208000029028 brain injury Diseases 0.000 claims 2
- 210000000481 breast Anatomy 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 230000007423 decrease Effects 0.000 claims 2
- 230000009547 development abnormality Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 210000003128 head Anatomy 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 201000002364 leukopenia Diseases 0.000 claims 2
- 231100001022 leukopenia Toxicity 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 208000037941 meningococcal disease Diseases 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 2
- 210000003739 neck Anatomy 0.000 claims 2
- 230000001613 neoplastic effect Effects 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 210000000496 pancreas Anatomy 0.000 claims 2
- 206010034674 peritonitis Diseases 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 230000000306 recurrent effect Effects 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 230000036303 septic shock Effects 0.000 claims 2
- 230000035939 shock Effects 0.000 claims 2
- 206010043554 thrombocytopenia Diseases 0.000 claims 2
- 230000009261 transgenic effect Effects 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0229854.5A GB0229854D0 (en) | 2002-12-20 | 2002-12-20 | Proteins |
| PCT/GB2003/005621 WO2004056859A1 (en) | 2002-12-20 | 2003-12-19 | Il-8-like proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006526386A JP2006526386A (ja) | 2006-11-24 |
| JP2006526386A5 true JP2006526386A5 (https=) | 2007-02-15 |
Family
ID=9950191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004561676A Abandoned JP2006526386A (ja) | 2002-12-20 | 2003-12-19 | Ｉｌ−８様タンパク質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060275259A1 (https=) |
| EP (1) | EP1578795A1 (https=) |
| JP (1) | JP2006526386A (https=) |
| AU (1) | AU2003290317A1 (https=) |
| CA (1) | CA2510029A1 (https=) |
| GB (1) | GB0229854D0 (https=) |
| IL (1) | IL169260A0 (https=) |
| NO (1) | NO20053512L (https=) |
| WO (1) | WO2004056859A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004106503A1 (en) * | 2003-05-27 | 2004-12-09 | Applied Research Systems Ars Holding N.V. | Novel il-8-like polypeptides |
| EP1843728B1 (en) * | 2005-01-26 | 2012-01-04 | The Procter & Gamble Company | Disposable pull-on diaper having a low force, slow recovery elastic waist |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7238860B2 (en) * | 2001-04-18 | 2007-07-03 | Mendel Biotechnology, Inc. | Yield-related polynucleotides and polypeptides in plants |
| JP2006149341A (ja) * | 2004-05-31 | 2006-06-15 | Sapporo Breweries Ltd | ９−脂肪酸ヒドロペルオキシドリアーゼ遺伝子 |
-
2002
- 2002-12-20 GB GBGB0229854.5A patent/GB0229854D0/en not_active Ceased
-
2003
- 2003-12-19 WO PCT/GB2003/005621 patent/WO2004056859A1/en not_active Ceased
- 2003-12-19 EP EP03782676A patent/EP1578795A1/en not_active Withdrawn
- 2003-12-19 JP JP2004561676A patent/JP2006526386A/ja not_active Abandoned
- 2003-12-19 US US10/540,180 patent/US20060275259A1/en not_active Abandoned
- 2003-12-19 CA CA002510029A patent/CA2510029A1/en not_active Abandoned
- 2003-12-19 AU AU2003290317A patent/AU2003290317A1/en not_active Abandoned
-
2005
- 2005-06-17 IL IL169260A patent/IL169260A0/en unknown
- 2005-07-18 NO NO20053512A patent/NO20053512L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hoyer et al. | Candida albicans agglutinin-like sequence (Als) family vignettes: a review of Als protein structure and function | |
| CA2735129A1 (en) | Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation | |
| JP2005532034A5 (https=) | ||
| JP2005528086A5 (https=) | ||
| JP2007526759A5 (https=) | ||
| JP2006506042A (ja) | Ｌａ１−ラクトバシルス株のゲノム | |
| WO2018067571A2 (en) | Computer implemented discovery of biomarkers for blood brain barrier disruption | |
| CN103923195B (zh) | 修饰型生物素结合蛋白 | |
| WO2024168965A1 (zh) | 人IL-1R1和人IL-1RAcP多肽片段组合的同源二聚体蛋白质与用途 | |
| JP2005528336A5 (https=) | ||
| JP2006526386A5 (https=) | ||
| CN118221791B (zh) | 一种Rv0653c蛋白、其抗体及应用 | |
| CN111154865B (zh) | 帕金森生物标志物及其在制备检测产品中的应用 | |
| CN111662909B (zh) | 心肌肌钙蛋白i特异性核酸适配体及其应用 | |
| CN104250649B (zh) | 皮肤角化‑少毛‑白甲综合征新的致病基因及其编码蛋白质和应用 | |
| RU2572343C2 (ru) | РЕКОМБИНАНТНАЯ ДНК pA4, РЕКОМБИНАНТНАЯ ДНК pQE 30-pA4, ОБЕСПЕЧИВАЮЩИЕ ПОЛУЧЕНИЕ ПОЛИПЕПТИДА A4, ШТАММ Esherichia coli M 15-A4, ТРАНСФОРМИРОВАННЫЙ РЕКОМБИНАНТНОЙ ПЛАЗМИДНОЙ ДНК pQE 30-pA4 И ЭКСПРЕССИРУЮЩИЙ РЕКОМБИНАНТНЫЙ ПОЛИПЕПТИД A4, РЕКОМБИНАНТНЫЙ ПОЛИПЕПТИД A4, ОБЛАДАЮЩИЙ СПОСОБНОСТЬЮ СЕЛЕКТИВНО СВЯЗЫВАТЬ ЧСА, АФФИННЫЕ СОРБЕНТЫ (ВАРИАНТЫ) И СПОСОБЫ УДАЛЕНИЯ ЧСА И IgG ИЗ СЫВОРОТКИ КРОВИ (ВАРИАНТЫ) | |
| JP2005500015A5 (https=) | ||
| JP2005500010A5 (https=) | ||
| JP5560608B2 (ja) | オートタキシンの精製方法 | |
| JP2006516888A5 (https=) | ||
| Honda et al. | Differential Th1/Th2 chemokine expression in interstitial pneumonia | |
| CN114752600A (zh) | 组氨酸标签的核酸适配体 | |
| JP2005500012A5 (https=) | ||
| JP2008509659A5 (https=) | ||
| CN106199019B (zh) | 一种用于检测冠心病的基因芯片及其试剂盒 |